Accelerate your portfolio expansion through strategic out-licensing with InstaPill®

We offer a robust selection of fully developed and pipeline-stage products, designed to meet evolving patient needs and regulatory standards. Our innovative orally disintegrating dosage forms not only enhance patient compliance but also unlock new market segments with minimal development risk.

Anti-Allergens; Children's Health F&B; Convenience; Halal Ingredients; International Approvals/Standards; Kosher Ingredients; Product Performance; Reputation; Small Orders Accepted; Whether you're seeking to strengthen your existing portfolio or enter new therapeutic categories, our out-licensing model provides a fast-track to commercial success — without the burden of early-stage R&D. Each product is crafted with global market adaptability in mind, ensuring smooth registration and rapid launch. From CNS and pain management to pediatric and geriatric care, our offerings are tailored for high-impact market entry. Let InstaPill® be your innovation engine — delivering ready-to-license solutions that combine scientific excellence with commercial viability.

Out-licensing.

India